Please do not adjust margins
Organic & Biomolecular Chemistry
Page 4 of 5
DOI: 10.1039/C6OB02133F
COMMUNICATION
Journal Name
Scheme 7 Plausible mechanistic pathway
of Scientific and Industrial Research (12th FYP project, ORIGIN-
CSC-0108), New Delhi, is greatly acknowledged.
Notes and references
1
(a) J. Clardy And C. Walsh, Nature, 2004, 432, 829; K. W.
Bentley, Nat. Prod. Rep., 2005, 22, 249. (c) A. Cave, M.
Leboeuf and P. G. Waterman, In Alkaloids: Chemical and
Biological Perspective; S. W. Pelletier, Eds.; Wiley: London,
1987; Vol. 5, p 245. (d) S. G. Bradley and F. Marciano-Cabral,
In Principles of Pharmacology: Antiparasitic Drugs; P. L.
Munson, R. A. Mueller and G. R. Breese, Eds.; Chapman &
Hall: New York, 1994; Chapter 100. (e) R. B. Taylor, M.
MacCoss, and A. D. G. Lawson, J. Med. Chem., 2014, 57
5845.
,
The synthetic utility of the products
3 and 5 were also
demonstrated by further diversification of some selected
compounds (Schemes 8). Attempt towards deacetylation of 3f
to the corresponding dihydroindenopyridine using NaOH in
methanol resulted in aromatization and oxidation of the
2
For, Fused pyridines: (a) G. R. Heintzelman, K. M. Averill and
J. H. Dodd, World Patent WO 2002085894 A1 20021031,
2002. (b) G. R Heintzelman, K. M. Averill, J. H. Dodd, K. T.
Demarest, Y. Tang and P. F. Jackson, U.S. Patent US
2004082578 A1 20040429, 2004. (c) R. Miri, K. Javidnia, B.
Hemmateenejad, A. Azarpira and Z. Amirghofran, Bioorg.
Med. Chem., 2004, 12, 2529. Fused isoquinolines: (d) R. P.
Bakshi, D. Sang, A. Morrell, M. Cushman and T. A. Shapiro,
Antimicrob. Agents. Chemother., 2009, 53, 123. (e) M.
Nagarajan, X. Xiao, S. Antony, G. Kohlhagen, Y. Pommier and
M. Cushman, J. Med. Chem., 2003, 46, 5712. (f) R. Balaña-
Fouce, C. F. Prada, J. M. Requena, M. Cushman, Y. Pommier,
R. Álvarez-Velilla, J. M. Escudero-Martínez, E. Calvo-Álvarez,
Y. Pérez-Pertejo and R. M. Reguera, Antimicrob. Agents.
Chemother., 2012, 56, 5264.
methylene carbon to afford indenopyridinone 11 in
a
moderate yield (Schemes 7a).13 However, oxidation of 3f using
DDQ afforded the corresponding indenopyridine 12 (Scheme
8a). In contrast, when 5f was subjected under DDQ mediated
oxidative conditions the corresponding N-acetylated
benzo[f]isoquinolin (13) was formed (Schemes 8b).
Scheme 8 Synthetic utility of products 3f & 5f
3
(a) J. Cortijo, V. Villagrasa, R. Pons, L. Berto, M. MartõÂ-
Cabrera, M. Martinez-Losa, T. Domenech, J. Beleta and E. J.
Morcillo, Br. J. Pharmacol., 1999, 127, 1641. (b) H. A.
Lasheul, D. M. Hartley, D. Balakhaney, A. Aggarwal, S.
Teichberg and D. J. Callaway, J. Biol. Chem., 2002, 8, 42881.
(c) G. C. Cotzias, P. S. Papavasiliou, C. Fehling, B. Kaufman
and I. Mena, N. Engl. J. Med., 1970, 282, 31. (d) C. M. H.
Stibe, P. A. Kempster, A. J. Lees and G. M. Stern, Lancet,
1970, 331, 403.
4
5
4. T. Li, P.J. Houghton, S. D. Desai, P. Daroui, A. A. Liu, E. S.
Hars, A. A. Ruchelman, E. J. LaVoie and L. F. Liu, Cancer. Res.,
2003, 63, 8400.
5. (a) E. J. Massaro, Handbook of Neurotoxicology, N. J.
Totowa, Humana Press, 2002; 237. (b) D. M. Balitz, J. A.
Bush, W. T. Bradner, T. W. Doyle, F. A. O'Herron and D. E.
Nettleton, J. Antibiot., 1982, 35, 259. (c) M. Hassani, W. Cai,
K. H. Koelsch, D. C. Holley, A. S. Rose, F. Olang, P. Jayana,
Lineswala, W. G. Holloway, J. M. Gerdes, M. Behforouz and
H. D. Beall, J. Med. Chem., 2008, 51, 3104.
In conclusion, we have disclosed a novel strategy for the
synthesis of functionalised N-subtituted 1,2-dihydropyridines,
indenopyridines, and 5,6-dihydroisoquinolines from readily
available simple substrates. The synthetic utility of the
products has led to azafluorenone derivatives. These
potentially bioactive derivatives could be easily transformed
into polycyclic building blocks that are difficult to access from
traditional methods. The protocol offers mild condition, short
reaction time, and convenient one-pot operation, without dry
solvents or inert atmosphere. Further experiments based on
other α,β-unsaturated ketones are in progress.
6
7
(a) A. Padwa, T. M. Heidelbugh and J. T. Kuethe, J. Org.
Chem., 2000, 65, 2368. (b) D. Muller, R. A. Davis, S. Duffy, V.
M. Avery, D. Camp and R. J. Quinn, J. Nat. Prod., 2009, 72
,
1538. (c) G. A. Kraus and A. Kempema, J. Nat. Prod., 2010,
73, 1967.
For, Synthesis of Pyridines: (a) M. Blumel, P. Chauhan, R.
Hahn, G. Raabe and D. Enders, Org. Lett., 2014, 16, 6012. (b)
B. Wanner, J. Mahatthananchai, J. W. Bode, Org. Lett., 2011,
13, 5378. (c) J. P. Wan, C. C. J. Loh, F. Pan, D. Enders, Chem.
Commun., 2012, 48, 10049. Synthesis of Isoquinolines: (d) R.
Grigg, E. E. Elboray, S. Akkarasamiyo, N. Chuanopparat, H. A.
Dondas, H. H. Abbas-Temirek, L. W. G. Fishwick, M. F. Aly, B.
Kongkathip, N. Kongkathip, Chem. Commun., 2016, 52, 164.
(e) M. Yamauchi, M. Morimoto, T. Miura and M. J.
We thank Dr. K. V. Radhakrishnan and Dr. Ravi Shankar
Lankalapalli for their constant support and fruitful discussions.
F. S. and A. K. T. thank UGC and CSIR for research fellowships.
We thank Dr. Sunil Varughese, CSIR-NIIST, Trivandrum, for
single-crystal X-ray analysis. Financial assistance from Council
Murakami, J. Am. Chem. Soc., 2010, 132, 54. (f) Y. Ochi, T.
Kurahashi and S. Matsubara, Org. Lett., 2011, 13, 1374. (g) H.
Wang and Glorius, F. Angew. Chem. Int. Ed., 2012, 51, 7318.
4
|
J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins